Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 811 results for "Treatment For Ovarian Cancer"

The Market for Personalized Gene Therapy Treatments for Cancer

(http://www.researchandmarkets.com/research/p54ckt/the_market_for) has announced the addition of the report to their offering. In addition the report provides: Historically, cancer treatments have been very invasive and detrimental process to the ... Pettinga Financial Advisors, 2 days ago
[x]  

8 images for Treatment For Ovarian Cancer

Starkville Daily News, 2 weeks ago
Starkville Daily News, 2 weeks ago
Tasmania Mercury, 4 weeks ago
Franklin Credit Management Corporation, 1 week ago
Yahoo! Finance, 1 week ago
KXXV-TV, 3 weeks ago
Starkville Daily News, 2 weeks ago
Starkville Daily News, 2 weeks ago
Wall Street Select

Insys receives orphan drug designation from FDA for ovarian cancer treatment

Insys Therapeutics, Inc., a specialty pharmaceutical company, has received orphan drug designation, or ODD, from the FDA for its Liposomal Encapsulated Paclitaxel, or LEP, candidate for the treatment of ovarian cancer. "We are pleased to have ...
 Individual.com1 day ago FDA grants orphan drug status to ovarian cancer treatment  Orthopedics Today4 days ago Aspyrian raises $8.5M for cancer therapy; Insys gets orphan status; BioCryst gains FDA fast track;  FierceBiotech3 days ago Insys Therapeutics Secures FDA Orphan Drug Designation for Ovarian Cancer Treatment [Health & Beauty Close - Up]  Pharmacy Choice1 day ago
[x]  
Reuters

AstraZeneca's ovarian cancer drug gets US approval

AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the US health regulator, a day after the treatment was approved by the European Commission. AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the ...
 Economic Times1 month ago Roche says Avastin approved in U.S. for type of ovarian cancer  Reuters2 months ago
Auto Week

NASCAR driver Martin Truex Jr.'s girlfriend completes chemotherapy

Sherry Pollex finishes ovarian cancer treatment Driver Martin Truex Jr. shared some welcome offtrack news during Furniture Row Racing 's media session on Thursday morning at the Charlotte Convention Center. Truex's girlfriend Sherry Pollex has been ...
 Auto Week20 hours ago Martin Truex Jr.'s girlfriend continues cancer fight  Austin American Statesman23 hours ago Martin Truex, Jr. and girlfriend, Sherry Pollex, move forward on road to recovery  Austin American Statesman1 day ago

Ovarian Cancer treatment market in Asia-Pacific to undergo modest growth by 2020, says GBI Research

The Asia-Pacific (APAC) therapeutics market for Ovarian Cancer (OC) will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth Rate (CAGR) of 5.1%, says business intelligence provider GBI ...
 European Pharmaceutical Review5 hours ago Modest growth expected for Asia-Pacific ovarian cancer drug market  Pharma Letter5 hours ago

NHRI lauds ovarian cancer study

The National Health Research Institutes (NHRI) yesterday announced a potential breakthrough in the treatment of ovarian cancer — the discovery of a steroid medication that may help inhibit metastasis of the cancer and/or its recurrence. The ...
 Taipei Times Online20 hours ago

Study of rare ovarian cancer featured in ASCO annual report

A groundbreaking TGen-led discovery of the likely genetic cause of an ovarian cancer that strikes young women and girls is featured in the annual report of the American Society of Cancer Oncology (ASCO). Developed under the guidance of an expert ...
 Science Daily5 days ago Discovery of 'genetic superhighway' mutation expected to lead to new treatments for rare ovarian cancer that strikes young women and girls  Medical News Today1 week ago TGen-led study of rare ovarian cancer featured in ASCO 'Cancer Advances' annual report  EurekAlert!1 week ago

Forum Post: Have you experience of intravenous vitamin C treatment?

I was diagnosed with ovarian cancer in June 2011. To date I have had 5 courses of chemotherapy to control the disease. There seems to be no effective treatment for my condition, and in the last 18 months I have been more often on chemotherapy than ...
 Macmillan Cancer Support1 week ago Forum Post: Re: Have you experience of intravenous vitamin C treatment?  Macmillan Cancer Support1 week ago
Med India

Animal Study Finds Antiangiogenic Treatment Improves Survival in Ovarian Cancer

Official data has revealed that epithelial ovarian cancer is the most lethal cancer of the female reproductive organs. It results in more than 200,000 new cases and more than 125,000 deaths each year worldwide. Because symptoms tend to be vague, 80 percent of ...
 Med India2 months ago
Ecancer Medicalscience

Researchers pinpoint two genes that trigger severest form of ovarian cancer

In the battle against ovarian cancer, UNC School of Medicine researchers have created the first mouse model of the worst form of the disease and found a potential route to better treatments and much-needed diagnostic screens. Led by Terry ...
 Ecancer Medicalscience4 minutes ago Researchers Discover Two Genes That Trigger the Worst Form of Ovarian Cancer  Med India3 days ago Researchers pinpoint 2 genes that trigger severest form of ovarian cancer  EurekAlert!3 days ago Two Genes Trigger Severest Form of Ovarian Cancer in Mouse Model  ALN1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less